Reply to Nyman, U.; Aspelin, P. Regarding Iodixanol for Pediatric CTA. Comment on “Pop, M. Cardiothoracic CTA in Infants Referred for Aortic Arch Evaluation—Retrospective Comparison of Iomeprol 350, Ioversol 350, Iopromide 370 and Iodixanol 320. Children 2021, 8, 949”

Detalles Bibliográficos
Autor principal: Pop, Marian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Reply
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140064/
https://www.ncbi.nlm.nih.gov/pubmed/35626886
http://dx.doi.org/10.3390/children9050709
_version_ 1784715007724879872
author Pop, Marian
author_facet Pop, Marian
author_sort Pop, Marian
collection PubMed
description
format Online
Article
Text
id pubmed-9140064
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91400642022-05-28 Reply to Nyman, U.; Aspelin, P. Regarding Iodixanol for Pediatric CTA. Comment on “Pop, M. Cardiothoracic CTA in Infants Referred for Aortic Arch Evaluation—Retrospective Comparison of Iomeprol 350, Ioversol 350, Iopromide 370 and Iodixanol 320. Children 2021, 8, 949” Pop, Marian Children (Basel) Reply MDPI 2022-05-12 /pmc/articles/PMC9140064/ /pubmed/35626886 http://dx.doi.org/10.3390/children9050709 Text en © 2022 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Reply
Pop, Marian
Reply to Nyman, U.; Aspelin, P. Regarding Iodixanol for Pediatric CTA. Comment on “Pop, M. Cardiothoracic CTA in Infants Referred for Aortic Arch Evaluation—Retrospective Comparison of Iomeprol 350, Ioversol 350, Iopromide 370 and Iodixanol 320. Children 2021, 8, 949”
title Reply to Nyman, U.; Aspelin, P. Regarding Iodixanol for Pediatric CTA. Comment on “Pop, M. Cardiothoracic CTA in Infants Referred for Aortic Arch Evaluation—Retrospective Comparison of Iomeprol 350, Ioversol 350, Iopromide 370 and Iodixanol 320. Children 2021, 8, 949”
title_full Reply to Nyman, U.; Aspelin, P. Regarding Iodixanol for Pediatric CTA. Comment on “Pop, M. Cardiothoracic CTA in Infants Referred for Aortic Arch Evaluation—Retrospective Comparison of Iomeprol 350, Ioversol 350, Iopromide 370 and Iodixanol 320. Children 2021, 8, 949”
title_fullStr Reply to Nyman, U.; Aspelin, P. Regarding Iodixanol for Pediatric CTA. Comment on “Pop, M. Cardiothoracic CTA in Infants Referred for Aortic Arch Evaluation—Retrospective Comparison of Iomeprol 350, Ioversol 350, Iopromide 370 and Iodixanol 320. Children 2021, 8, 949”
title_full_unstemmed Reply to Nyman, U.; Aspelin, P. Regarding Iodixanol for Pediatric CTA. Comment on “Pop, M. Cardiothoracic CTA in Infants Referred for Aortic Arch Evaluation—Retrospective Comparison of Iomeprol 350, Ioversol 350, Iopromide 370 and Iodixanol 320. Children 2021, 8, 949”
title_short Reply to Nyman, U.; Aspelin, P. Regarding Iodixanol for Pediatric CTA. Comment on “Pop, M. Cardiothoracic CTA in Infants Referred for Aortic Arch Evaluation—Retrospective Comparison of Iomeprol 350, Ioversol 350, Iopromide 370 and Iodixanol 320. Children 2021, 8, 949”
title_sort reply to nyman, u.; aspelin, p. regarding iodixanol for pediatric cta. comment on “pop, m. cardiothoracic cta in infants referred for aortic arch evaluation—retrospective comparison of iomeprol 350, ioversol 350, iopromide 370 and iodixanol 320. children 2021, 8, 949”
topic Reply
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140064/
https://www.ncbi.nlm.nih.gov/pubmed/35626886
http://dx.doi.org/10.3390/children9050709
work_keys_str_mv AT popmarian replytonymanuaspelinpregardingiodixanolforpediatricctacommentonpopmcardiothoracicctaininfantsreferredforaorticarchevaluationretrospectivecomparisonofiomeprol350ioversol350iopromide370andiodixanol320children20218949

Ejemplares similares